L’Oréal buys CeraVe, AcneFree, Ambi brands from Valeant
CLICHY, N.Y. — L’Oréal plans to acquire the CeraVe, AcneFree and Ambi skin care brands from Valeant Pharmaceuticals International Inc. for $1.3 billion in cash. Plans call for CeraVe, AcneFree and Ambi to become part of the L’Oréal Active Cosmetics Division, which includes the La Roche-Posay, Vichy and SkinCeuticals brands developed with and endorsed by
